Structures by: Basiuk V. A.
Total: 7
C11H10N4O2
C11H10N4O2
Organic & biomolecular chemistry (2020) 18, 8 1657-1670
a=7.345(5)Å b=7.435(6)Å c=11.625(9)Å
α=74.87(3)° β=89.96(3)° γ=65.91(3)°
C20H18F3N3
C20H18F3N3
Organic & biomolecular chemistry (2020) 18, 8 1657-1670
a=14.409(2)Å b=7.2189(10)Å c=17.976(3)Å
α=90° β=107.935(7)° γ=90°
C13H15N3
C13H15N3
Organic & biomolecular chemistry (2020) 18, 8 1657-1670
a=8.564(4)Å b=22.313(11)Å c=25.094(12)Å
α=90° β=93.048(7)° γ=90°
C13H14IN3
C13H14IN3
Organic & biomolecular chemistry (2020) 18, 8 1657-1670
a=11.5238(10)Å b=9.5869(9)Å c=12.6216(11)Å
α=90° β=106.002(3)° γ=90°
[Ni(Me6trans[14]teteneN4)](ClO4)2
(C16H28N4Ni),(ClO4)2
Acta Crystallographica Section C (1999) 55, 2 160-162
a=6.866(3)Å b=9.101(4)Å c=9.927(4)Å
α=100.62(2)° β=90.85(3)° γ=109.34(2)°
[Ni(rac-Me6[14]aneN4)(nicotinato)]ClO4
C22H40N5NiO2,ClO4
Acta Crystallographica Section C (2001) 57, 5 553-555
a=10.474(2)Å b=13.221(2)Å c=20.288(3)Å
α=90° β=91.330(10)° γ=90°
2,2,5,5,8,8-hexamethyl-4,5,7,8-tetrahydroimidazo[1,2-a]pyrazine- -3,6-dione
C12H19N3O2
Acta Crystallographica Section C (2000) 56, 5 598-599
a=5.9020(10)Å b=8.628(2)Å c=12.949(2)Å
α=95.020(10)° β=93.340(10)° γ=102.450(10)°